Publication | Closed Access

Design, synthesis, molecular docking and biological evaluation of novel pyrazole derivatives bearing quinoxalinone moiety as multi-targeted anticancer agents

Medicinal ChemistryNovel Pyrazole DerivativesMedicinePolymer-drug ConjugatePharmacologyMulti-targeted Anticancer AgentsAnti-cancer AgentDrug DevelopmentMolecular DockingRadiation OncologyDrug Discovery